Vertical Data Inc. amends bylaws
Vertical Data Inc. filed an amendment to its bylaws. The prior text was truncated; the specific changes were not detailed.
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Vertical Data Inc. filed an amendment to its bylaws. The prior text was truncated; the specific changes were not detailed.
Greenland Mines Ltd filed a pre-funded warrant as part of an EX-4.1 exhibit, dated June 3, 2025. This SEC filing indicates the company's progress on updating its capitalization agr…
Alcoa Corp filed an exhibit relating to the indenture for its 2026 notes issued on September 23, 2026, amending previous terms. This filing provides necessary updates to regulatory…
Arcturus confirms receipt of FDA clearance for its LEAP mRNA platform technology. This regulatory milestone underpins the development of its COVID-19 vaccine candidate, LURV126. In…
Ready Capital Corp had consents to amend the indenture governing its 7.375% Senior Notes due 2027, as authorized by the Eighth Supplemental Indenture.
Aditxt Inc. will be delisted from Nasdaq as its stock has been suspended since June 25, 2026. This regulatory event will have no impact on the company's fundamental business operat…
BioCardia updated on its regulatory submission timelines, noting a Q4 2026 PMDA Shonin application and a Q4 2026 De Novo pre-submission for its Helix platform.
The company received a new patent from the Mexican Patent Office for its lung-targeted liposomal Annamycin formulation, bolstering its intellectual property portfolio ahead of a pi…
Knife River Corporation filed an exhibit titled 'September 2026 Conference Presentation', which includes forward-looking financial statements and information regarding its growth s…
The company regained compliance with the Nasdaq minimum bid price requirement and plans to address remaining listing standards by December 2026 while advancing clinical programs.
BBA Consultants USA LP consented to the use of their feasibility study in Ivanhoe Electric's 8-K filing regarding the Santa Cruz Copper Project.
The company announced that partner Roche's trial met its primary endpoint, offering a treatment option that may prevent kidney failure.
The Federal Reserve Board has approved the application submitted by BancFirst Corporation. No summary details are included in the press release.
NW Natural subsidiary SiEnergy reached a settlement in a Texas general rate case to increase revenue by $8.6 million, which is subject to Railroad Commission of Texas approval. If …
Preliminary OLE data shows fasedienol nasal spray was well-tolerated and clinically improved social anxiety symptoms over four months, contributing to its potential for everyday us…
Quoin Pharmaceuticals announced the FDA granted Fast Track designation to QRX003 for Peeling Skin Syndrome, a disease with no approved treatment. This is the second indication for …
Non-Invasive Monitoring Systems filed an amendment to delete Article VIII regarding indemnification, approved by the board and shareholders in 2026. Details of the deleted provisio…
Citizens & Northern Corporation amended its Certificate of Incorporation and Bylaws to allow shareholders to conduct annual meetings entirely via electronic technology. The update …
SRK Consulting (U.S.) Inc. consented to the use of the technical report for its Granite Creek Mine. The company provided the consent as an expert for the 8-K filing and related reg…
CMS recommended retaining EsoGuard's gapfill payment basis and the AMA approved a Category III code for EsoCheck, signaling progress in revenue recognition for the company's colore…